Incentivizing resilient supply chain design to prevent drug shortages: policy analysis using two- and multi-stage stochastic programs

References

• AHA, ASA, ASCO, ASHP, ASPEN, and ISMP (2017) Letter to Congressman Griffith and Congresswoman DeGette. Available at https://www.asahq.org/∼/media/sites/asahq/files/public/advocacy/alerts/washingtonalerts/2017121-joint-letter-to-ec-on-svp-shortages-final.pdf?la=en. (accessed 28 March 2018).
   Google Scholar
• Almansoori, A. and Shah, N. (2012) Design and operation of a stochastic hydrogen supply chain network under demand uncertainty. International Journal of Hydrogen Energy, 37(5), 3965–3977.
   Web of Science ®Google Scholar
• ASHP (2013) April 2013 Drug Shortages Summit Report: Evaluating Long-Term Solutions. Available at https://www.ashp.org/-/media/assets/drug-shortages/docs/drug-resources-2013-drug-shortages-summit.ashx. (accessed 14 March 2019).
   Google Scholar
• Atan, Z. and Snyder, LV. (2012) Inventory strategies to manage supply disruptions, in Supply Chain Disruptions, Springer, London, UK, pp.115–139.
   Google Scholar
• Azghandi, R., Griffin, J. and Jalali, M.S. (2018). Minimization of drug shortages in pharmaceutical supply chains: A simulation-based analysis of drug recall patterns and inventory policies. Complexity, 2018, 1–14.
   Google Scholar
• Berk, E. and Arreola-Risa, A. (1994) Note on “future supply uncertainty in EOQ models.” Naval Research Logistics, 41, 129–132.
   Web of Science ®Google Scholar
• Bundschuh, M., Klabjan, D. and Thurston, D.L. (2003) Modeling robust and reliable supply chains. Optimization Online E-Print, Available at http://www.optimization-online.org/DB_FILE/2003/07/679.pdf. (accessed 3 September 2019).
   Google Scholar
• Chabner, B.A. (2011) Drug shortages — A critical challenge for the generic-drug market. New England Journal of Medicine, 365(23), 2147–2149.
   PubMed Web of Science ®Google Scholar
• Chopra, S. and Sodhi, M.S. (2004) Managing risk to avoid supply-chain breakdown. MIT Sloan Management Review, 46(1), 53–61.
   Web of Science ®Google Scholar
• CMS (2018a) Medicare enrollment dashboard. Available at https://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-Reports/CMSProgramStatistics/Dashboard.html (accessed May 2018).
   Google Scholar
• CMS (2018b) Part B: National summary data file. Available at https://www.cms.gov/Research-Statistics-Data-and-Systems/Downloadable-Public-Use-Files/Part-B-National-Summary-Data-File/Overview.html (accessed 7 May 2018).
   Google Scholar
• Conti, R.M. (2011) An Economic Assessment of the Causes and Policy Implications of Current Specialty Drug Shortages. Washington, DC. Available at https://www.finance.senate.gov/imo/media/doc/Conti%20Testimony.pdf. (accessed 3 September 2019).
   Google Scholar
• Dada, M., Petruzzi, N.C. and Schwarz, L.B. (2007) A newsvendor’s procurement problem when suppliers are unreliable. Manufacturing & Service Operations Management, 9(1), 9–32.
   Web of Science ®Google Scholar
• Doroudi, R., Azghandi, R., Feric, Z., Mohaddesi, O., Sun, Y., Griffin, J., … Harteveld, C.  (2018) An integrated simulation framework for examining resiliency in pharmaceutical drug supply chains considering human behaviors, in Proceedings of the Winter Simulation Conference. IEEE, Gothenburg, Sweden, pp. 88–99.
   Google Scholar
• “Drug Shortages,” Health Affairs Health Policy Brief, (September 11, 2014). doi:10.1377/hpb20140911.148389
   Google Scholar
• Fattahi, M., Govindan, K. and Keyvanshokooh, E. (2017) Responsive and resilient supply chain network design under operational and disruption risks with delivery lead-time sensitive customers. Transportation Research Part E: Logistics and Transportation Review, 101, 176–200.
   Web of Science ®Google Scholar
• FDA (2013). Strategic plan for preventing and mitigating drug shortages, (October), 1–40. Available at https://www.fda.gov/media/86907/download (accessed 3 September 2019).
   Google Scholar
• FDA (2018a) Drugs@FDA: FDA approved drug products. Available at https://www.accessdata.fda.gov/scripts/cder/daf/ (accessed 5 September 2018).
   Google Scholar
• FDA (2018b). Generic drug user fee amendments. Available at https://www.fda.gov/ForIndustry/UserFees/GenericDrugUserFees/default.htm (accessed 12 April 2018).
   Google Scholar
• FDA (2018c). National drug code directory. Available at https://www.fda.gov/Drugs/InformationOnDrugs/ucm142438.htm (accessed 12 April 2018).
   Google Scholar
• Fourer, R., Gay, D.M. and Kernighan, B.W. (2002) AMPL: A Modeling Language for Mathematical Programming. Thomson Brooks/Cole, Pacific Grove, CA.
   Google Scholar
• Fox, E.R., Sweet, B.V. and Jensen, V. (2014) Drug shortages: A complex health care crisis. Mayo Clinic Proceedings, 89(3), 361–373.
   Web of Science ®Google Scholar
• Fox, E.R. and Tyler, L.S. (2013) Call to action: Finding solutions for the drug shortage crisis in the United States. Clinical Pharmacology and Therapeutics, 93(2), 145–147.
   Web of Science ®Google Scholar
• Frakt, A. (2016, May 31). Drug prices too high? Sometimes they're not costly enough. Available at https://www.nytimes.com/2016/05/31/upshot/drug-prices-too-high-sometimes-theyre-not-costly-enough.html (accessed 3 September 2019).
   Google Scholar
• GAO (2016) GAO-16-595: Drug shortages: Certain factors are strongly associated with this persistent public health challenge, (July). Available at https://www.gao.gov/products/GAO-16-595 (accessed 3 September 2019).
   Google Scholar
• Gatesman, M.L. and Smith, T.J. (2011) The shortage of essential chemotherapy drugs in the United States. New England Journal of Medicine, 365(18), 1653–1655.
   PubMed Web of Science ®Google Scholar
• Gehrett, B. (2012) A prescription for drug shortages. Journal of the American Medical Association, 307(2), 153–154.
   Web of Science ®Google Scholar
• Goldsack, J.C., Reilly, C., Bush, C., McElligott, S., Bristol, M.N., Motanya, U.N., … Domchek, S. (2014) Impact of shortages of injectable oncology drugs on patient care. American Journal of Health-System Pharmacy, 71(7), 571–578.
   Web of Science ®Google Scholar
• Gottlieb, S. (2018a) Update on recovery efforts in Puerto Rico, and continued efforts to mitigate IV saline and amino acid drug shortages. Available at https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm591391.htm (accessed 17 April 2019).
   Google Scholar
• Gottlieb, S. (2018b) Statement by FDA Commissioner Scott Gottlieb, M.D., on formation of a new drug shortages task force and FDA’s efforts to advance long-term solutions to prevent shortages. Available at https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm613346.htm (accesssed 18 July 2018).
   Google Scholar
• Govindan, K., Fattahi, M. and Keyvanshokooh, E. (2017) Supply chain network design under uncertainty: A comprehensive review and future research directions. European Journal of Operational Research, 263(1), 108–141.
   Web of Science ®Google Scholar
• Guillén, G., Mele, F.D., Espuña, A. and Puigjaner, L. (2006) Addressing the design of chemical supply chains under demand uncertainty. Industrial & Engineering Chemistry Research, 45(22), 7566–7581.
   Web of Science ®Google Scholar
• Gupta, D.K. and Huang, S.-M. (2013) Drug shortages in the United States: A critical evaluation of root causes and the need for action. Clinical Pharmacology and Therapeutics, 93(2), 133–135.
   PubMed Web of Science ®Google Scholar
• Gurler, U. and Parlar, M. (1997) An inventory problem with two randomly available suppliers. Operations Research, 45(6), 904–918.
   Web of Science ®Google Scholar
• Haninger, K., Jessup, A. and Koehler, K. (2011) 2011 ASPE issue brief: Economic Analysis of the causes of drug shortages. Available at https://aspe.hhs.gov/report/economic-analysis-causes-drug-shortages. (accessed 3 September 2019).
   Google Scholar
• Ho, W., Zheng, T., Yildiz, H. and Talluri, S. (2015) Supply chain risk management: A literature review. International Journal of Production Research, 53(16), 5031–5069.
   Web of Science ®Google Scholar
• Hopp, W.J. and Yin, Z. (2006) Protecting supply chain networks against catastrophic failures. Working Paper, Department of Industrial Engineering and Management Science, Northwestern University, Evanston, IL.
   Google Scholar
• Hu, X., Gurnani, H. and Wang, L. (2013) Managing risk of supply disruptions: Incentives for capacity restoration. Production and Operations Management, 22(1), 137–150.
   Web of Science ®Google Scholar
• IBM (2017) IBM ILOG CPLEX Optimization Studio 12.7. Armonk, NY.
   Google Scholar
• IBM Micromedex (2018) RED BOOK. Available at www.micromedexsolutions.com (accessed 26 April 2018).
   Google Scholar
• IMS (2011) Drug shortages: A closer look at products, suppliers and volume volatility, (November 11), 36, Parsippany, NJ.
   Google Scholar
• ISPE, and Pew Charitable Trusts (2017) Drug shortages: An exploration of the relationship between U.S. market forces and sterile injectable pharmaceutical products. Available at http://www.pewtrusts.org/∼/media/assets/2017/01/drug_shortages.pdf (accessed 3 September 2019).
   Google Scholar
• Jacobson, S.H., Sewell, E.C. and Proano, R.A. (2006) An analysis of the pediatric vaccine supply shortage problem. Health Care Management Science, 9(4), 371–389.
   Google Scholar
• Jarosławski, S., Azaiez, C., Korchagina, D. and Toumi, M. (2017) Quantifying the persisting orphan-drug shortage public health crisis in the United States. Journal of Market Access & Health Policy, 5(1), 1269473.
   Google Scholar
• Jia, J. and Zhao, H. (2017) Mitigating the U.S. drug shortages through Pareto-improving contracts. Production and Operations Management, 26(8), 1463–1480.
   Web of Science ®Google Scholar
• Kaakeh, R., Sweet, B.V., Reilly, C., Bush, C., DeLoach, S., Higgins, B., … Stevenson, J. (2011) Impact of drug shortages on U.S. health systems. American Journal of Health-System Pharmacy, 68(19), 1811–1819.
   PubMed Web of Science ®Google Scholar
• Karimi, H., Ekşioğlu, S.D. and Khademi, A. (2018). Analyzing tax incentives for producing renewable energy by biomass cofiring. IISE Transactions, 50(4), 332–344.
   Web of Science ®Google Scholar
• Kim, S., Cohen, M.A., Netessine, S. and Veeraraghavan, S. (2010) Contracting for infrequent restoration and recovery of mission-critical systems. Management Science, 56(9), 1551–1567.
   Web of Science ®Google Scholar
• Kim, S. and Scott Morton, F. (2015) A model of generic drug shortages: Supply disruptions, demand substitution, and price control. Working paper, Yale School of Management, Yale University, New Haven, CT
   Google Scholar
• Kleywegt, A.J., Shapiro, A. and Homem-de-Mello, T. (2002) The sample average approximation method for stochastic discrete optimization. SIAM Journal on Optimization, 12(2), 479–502.
   Web of Science ®Google Scholar
• Lakhdar, K. and Papageorgiou, L.G. (2008) An iterative mixed integer optimisation approach for medium term planning of biopharmaceutical manufacture under uncertainty. Chemical Engineering Research and Design, 86(3), 259–267.
   Google Scholar
• Link, M.P., Hagerty, K. and Kantarjian, H.M. (2012) Chemotherapy drug shortages in the United States: Genesis and potential solutions. Journal of Clinical Oncology, 30(7), 692–694.
   PubMed Web of Science ®Google Scholar
• Losada, C., Scaparra, M.P. and O’Hanley, J.R. (2012) Optimizing system resilience: A facility protection model with recovery time. European Journal of Operational Research, 217(3), 519–530.
   Web of Science ®Google Scholar
• MacKenzie, C.A., Barker, K. and Santos, J.R. (2014) Modeling a severe supply chain disruption and post-disaster decision making with application to the Japanese earthquake and tsunami. IIE Transactions, 46(12), 1243–1260.
   Web of Science ®Google Scholar
• Mak, H.Y. and Shen, Z.J. (2012) Risk diversification and risk pooling in supply chain design. IIE Transactions, 44(8), 603–621.
   Web of Science ®Google Scholar
• Marques, C.M., Moniz, S., de Sousa, J.P. and Barbosa-Póvoa, A.P. (2017) A simulation-optimization approach to integrate process design and planning decisions under technical and market uncertainties: A case from the chemical-pharmaceutical industry. Computers & Chemical Engineering, 106, 796–813.
   Web of Science ®Google Scholar
• McLaughlin, M., Kotis, D., Thomson, K., Harrison, M., Fennessy, G., Postelnick, M. and Scheetz, M.H. (2013) Effects on patient care caused by drug shortages: A survey. Journal of Managed Care Pharmacy, 19(9), 783–788.
   Web of Science ®Google Scholar
• Mousazadeh, M., Torabi, S.A. and Zahiri, B. (2015) A robust possibilistic programming approach for pharmaceutical supply chain network design. Computers & Chemical Engineering, 82, 115–128.
   Web of Science ®Google Scholar
• Nagurney, A. (2006) Supply Chain Network Economics: Dynamics of Prices, Flows and Profits. Edward Elgar Publishing, Cheltenham, UK.
   Google Scholar
• Narayana, S.A., Pati, R.K. and Vrat, P. (2014) Managerial research on the pharmaceutical supply chain - A critical review and some insights for future directions. Journal of Purchasing and Supply Management, 20(1), 18–40.
   Web of Science ®Google Scholar
• National Cancer Institute (2018) Surveillance, epidemiology, and end results (SEER) program. Available at https://seer.cancer.gov/ (accessed 6 July 2018).
   Google Scholar
• Nishiguchi, T. and Beaudet, A. (1998). The Toyota group and the Aisin fire. Sloan Management Review, 40(1), 49–59.
   Google Scholar
• O’Hanley, J.R. and Church, R.L. (2011) Designing robust coverage networks to hedge against worst-case facility losses. European Journal of Operational Research, 209(1), 23–36.
   Web of Science ®Google Scholar
• Palmer, E. (2016) Teva halts production at sterile injectables plant to address FDA concerns. Available at https://www.fiercepharma.com/pharma/teva-halts-production-at-sterile-injectables-plant-to-address-fda-concerns (accessed 30 January 2017).
   Google Scholar
• Parlar, M. and Berkin, D. (1991) Future supply uncertainty in EOQ models. Naval Research Logistics, 38(1), 107–121.
   Web of Science ®Google Scholar
• Parlar, M. and Perry, D. (1996) Inventory models of future supply uncertainty with single and multiple suppliers. Naval Research Logistics, 43(2), 191–210.
   Web of Science ®Google Scholar
• Peng, P., Snyder, L.V., Lim, A. and Liu, Z. (2011). Reliable logistics networks design with facility disruptions. Transportation Research Part B: Methodological, 45(8), 1190–1211.
   Web of Science ®Google Scholar
• PharmaCompass (2018) PharmaCompass. Available at www.pharmacompass.com (accessed 17 May 17 2018).
   Google Scholar
• Qi, L., Shen, Z.-J. M. and Snyder, L.V. (2009) A continuous-review inventory model with disruptions at both supplier and retailer. Production and Operations Management, 18(5), 516–532.
   Web of Science ®Google Scholar
• Reed, B.N., Fox, E.R., Konig, M., Jackevicius, C.A., Masoudi, F.A., Rabinstein, A.A. and Page, R.L. (2016) The impact of drug shortages on patients with cardiovascular disease: Causes, consequences, and a call to action. American Heart Journal, 175, 130–141.
   Web of Science ®Google Scholar
• Roberts, R., Ruthazer, R., Chi, A., Grover, A., Newman, M., Bhat, S., … Devlin, J.W. (2012) Impact of a national propofol shortage on duration of mechanical ventilation at an academic medical center. Critical Care Medicine, 40(2), 406–411.
   Web of Science ®Google Scholar
• Rudge, S. (2012) The cost of pharmaceutical facilities. Available at http://rmcpharmanews.blogspot.com/2012/12/the-cost-of-pharmaceutical-facilities.html (accessed 5 September 2018)
   Google Scholar
• Saedi, S., Kundakcioglu, O.E. and Henry, A.C. (2016) Mitigating the impact of drug shortages for a healthcare facility: An inventory management approach. European Journal of Operational Research, 251(1), 107–123.
   Web of Science ®Google Scholar
• Saghafian, S. and Van Oyen, M.P. (2012) The value of flexible backup suppliers and disruption risk information: Newsvendor analysis with recourse. IIE Transactions, 44(10), 834–867.
   Web of Science ®Google Scholar
• Schmitt, A.J. (2011) Strategies for customer service level protection under multi-echelon supply chain disruption risk. Transportation Research Part B: Methodological, 45(8), 1266–1283.
   Web of Science ®Google Scholar
• Schmitt, A.J., Snyder, L.V. and Shen, Z.J.M. (2010) Inventory systems with stochastic demand and supply: Properties and approximations. European Journal of Operational Research, 206(2), 313–328.
   Web of Science ®Google Scholar
• Schmitt, A.J., Sun, S.A., Snyder, L.V. and Shen, Z.J.M. (2015) Centralization versus decentralization: Risk pooling, risk diversification, and supply chain disruptions. Omega, 52, 201–212.
   Web of Science ®Google Scholar
• Schmitt, A.J. and Tomlin, B. (2012) Sourcing strategies to manage supply disruptions, in Supply Chain Disruptions: Theory and Practice of Managing Risk, H. Gurnani, A. Mehrotra, S. Ray, (eds.), Springer, London. pp. 51–72.
   Google Scholar
• SeaRates (2018) Logistics Explorer. Available at https://www.searates.com/reference/portdistance/ (accessed 27 April 2018).
   Google Scholar
• Shah, N. (2004) Pharmaceutical supply chains: Key issues and strategies for optimisation. Computers and Chemical Engineering, 28(6–7), 929–941.
   Web of Science ®Google Scholar
• Snyder, L.V., Atan, Z., Peng, P., Rong, Y., Schmitt, A.J. and Sinsoysal, B. (2016) OR/MS models for supply chain disruptions: A review. IIE Transactions, 48(2), 89–109.
   Web of Science ®Google Scholar
• Snyder, L.V. and Daskin, M.S. (2005) Reliability models for facility location: The expected failure cost case. Transportation Science, 39(3), 400–416.
   Web of Science ®Google Scholar
• Snyder, L.V. and Shen, Z.-J. M. (2006) Supply and demand uncertainty in multi-echelon supply chains. Available at https://shen.ieor.berkeley.edu/papers/paper38.pdf (accessed 3 September 2019).
   Google Scholar
• Song, J.-S. and Zipkin, P. (2009) Inventories with multiple supply sources and networks of queues with overflow bypasses. Management Science, 55(3), 362–372.
   Web of Science ®Google Scholar
• Song, J.-S. and Zipkin, P.H. (1996) Inventory control with information about supply conditions. Management Science, 42(10), 1409–1419.
   Web of Science ®Google Scholar
• Tang, C.S. (2006) Perspectives in supply chain risk management. International Journal of Production Economics, 103(2), 451–488.
   Web of Science ®Google Scholar
• Tang, O. and Musa, S.N. (2011) Identifying risk issues and research advancements in supply chain risk management. International Journal of Production Economics, 133(1), 25–34.
   Web of Science ®Google Scholar
• Tang, S.Y., Gurnani, H. and Gupta, D. (2014) Managing disruptions in decentralized supply chains with endogenous supply process reliability. Production and Operations Management, 23(7), 1198–1211.
   Web of Science ®Google Scholar
• Thomas, K. and Kaplan, S. (2017, October 4). Hurricane damage in Puerto Rico leads to fears of drug shortages nationwide. Available at https://www.nytimes.com/2017/10/04/health/puerto-rico-hurricane-maria-pharmaceutical-manufacturers.html (accessed 3 September 2019).
   Google Scholar
• Tomlin, B. (2006) On the value of mitigation and contingency strategies for managing supply chain disruption risks. Management Science, 52(5), 639–657.
   Web of Science ®Google Scholar
• Tucker, E.L., Cao, Y., Fox, E.R. and Sweet, B.V. (2019). The drug shortage era: A scoping review of the literature 2001–2019. Working Paper. Department of Industrial and Operations Engineering, University of Michigan, Ann Arbor, MI.
   Google Scholar
• US Congress (2012) FDASIA, Public Law 112–144. Available at https://www.congress.gov/112/plaws/publ144/PLAW-112publ144.pdf (accessed 3 September 2019).
   Google Scholar
• US Department of Commerce (2018) ACE TOOL: Shipping. https://acetool.commerce.gov/cost-risk-topic/shipping (accessed 27 April 2018).
   Google Scholar
• UUDIS (2016) Fox Data Summary.xlsx.
   Google Scholar
• Vail, E., Gershengorn, H.B., Hua, M., Walkey, A.J., Rubenfeld, G. and Wunsch, H. (2017) Association between US norepinephrine shortage and mortality among patients with septic shock. Journal of the American Medical Association, 317(14), 1433–1442.
   PubMed Web of Science ®Google Scholar
• Vizient (2019) Drug shortages and labor costs. https://www.vizientinc.com/-/media/documents/sitecorepublishingdocuments/public/vzdrugshortageslaborcost_fullreport.pdf (accessed 12 July 2019).
   Google Scholar
• Wiggins, B.S., Nappi, J., Fortier, C.R. and Taber, D.J. (2014) Cardiovascular drug shortages: Predominant etiologies, clinical implications, and management strategies. Annals of Pharmacotherapy, 48(9), 1177–1186.
   Web of Science ®Google Scholar
• Woodcock, J. and Wosinska, M. (2013) Economic and technological drivers of generic sterile injectable drug shortages. Clinical Pharmacology and Therapeutics, 93(2), 170–176.
   PubMed Web of Science ®Google Scholar